Latest News and Press Releases
Want to stay updated on the latest news?
-
WEST LAFAYETTE, Ind., April 08, 2026 (GLOBE NEWSWIRE) -- Professionals at federally qualified health centers, mental health centers, social service agencies, hospitals, institutes of higher...
-
VANCOUVER, British Columbia, April 07, 2026 (GLOBE NEWSWIRE) -- EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed a Research and Development...
-
AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly Amended agreement reflects growing excitement in the field for targeting intracellular Tau and...
-
Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer
-
Transgene et NEC Bio signent un accord de licence pour préparer les prochaines étapes de développement de TG4050 dans les cancers de la tête et du cou
-
LIVERMORE, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (“Advent” or the “Company”), an innovation driven leader in the fuel cell and hydrogen technology space, has...
-
WILMINGTON, Del., April 02, 2026 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a wireless, video, and AI technology research and development company, today announced that the company has...
-
ROLLING MEADOWS, Ill., April 01, 2026 (GLOBE NEWSWIRE) -- RYTHM, Inc. (Nasdaq: RYM) (“RYTHM” or the “Company”), America’s THC Company, today announced amendments to its existing trademark and recipe...
-
Axsome obtains exclusive global rights to balipodect, a potentially first-in-class selective phosphodiesterase 10A inhibitor Acquisition further expands Axsome’s industry-leading CNS portfolio with a...
-
PHILADELPHIA and VANCOUVER, British Columbia, March 31, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, BCTXL) (TSX: BCT) (“BriaCell”), a clinical-stage...